TrialClinical pharmacology in drug development2025

A 2-Part, Open-Label, Phase 1 Bioequivalence and Food-Effect Study of Ubrogepant in Healthy Adult Participants.

Ramesh Boinpally et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.